Some joint in Portugal i think.
I dont understand how they can come up with an under performing company, Admedus have ticked every box so far IMO.
Personally i dont believe a word of it because no one knows how cardiocel sales are going..
All we know is that uptake has been extremely positive with the amount of centres onboard.
In a few weeks we will get a small indication of sales but we wont really know until the following quarter when we can measure growth.
I just hope its good enough to shut the meercat up along with queen elizabeth.
Im feeling confident
new report, page-16
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.76 | $13.70 | $355.0K | 25.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 988 | $14.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.99 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |